. Their role is differentiated, and in fact, although the trapping concerns the monocytes, the activation regards the granulocytes. Recently we examined, in a group of 14 subjects with acute leg deep venous thrombosis (DVT), the granulocyte rheology, expressed as flow properties, the granulocyte membrane fluidity, and the granulocyte cytosolic Ca2+ content, before and after in vitro activation (prolonged for 5 and 15 minutes) with 4-phorbol 12-myristate 13-acetate (4) . Venous blood samples were drawn from the arm of subjects within 3 days from the diagnosis. No subject had undergone treatment with molecules that might have interfered with granulocyte rheology and function. Granulocyte flow properties, expressed as initial relative flow rate (IRFR), were examined using the St. George's Filtrometer (Carri-Med, Dorking, UK) (5). Granulocyte membrane fluidity was obtained marking intact cells with 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene and calculating the polarization degree (6) . The cytosolic Ca2+ concentration was evaluated marking intact granulocytes with Fura 2-AM (7) . At baseline (Table 1) , only the granulocyte cytosolic Ca2+ concentration distinguished normal subjects from DVT subjects. After activation, in normal subjects and in DVT subjects, a sig-TABLE 1. M~a~ ± ~D q/'~/!g ~~M/ocy~y~n~'oT ABLE 1. Means ± SD of the granulocyte filtration parameter, granulocyte membrane fluidity (expressed as ]-[4-(trimethylamino)phenyll-6-phenyl-1,3,5-hexatriene polarization degree), and cytosolic Ca2+ content (expressed as ratio between Fura2-Ca2+ and Fura2 fluorescencẽ~~~! <y) ~ ~or~a/ ~M~/ec~ <mJ !M ~M~/ec~ ~/! ~6ĩntensity) in normal subjects and in subjects with deep venous thrombosis at baseline and after activation with 4-phorbol 12-myristate 13-acetate * P < 0.001 versus normals. t P < 0.001 versus baseline. $ P < 0.01 versus baseline.
DVT, deep venous thrombosis; IRFR, initial relative flow rate; PMA, 4-phorbol 12-myristate 13-acetate; TMA-DPH, 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene. nificant variation in IRFR at 5 and 15 minutes was present (Table 1) , although in subjects with DVT this variation was significantly greater than in normal subjects, at both 5 minutes (P < 0.01) and 15 minutes (P < 0.001).
Although in normal subjects no variation was found after activation in granulocyte membrane fluidity or cytosolic Ca2+ concentration, in subjects with DVT, we observed a decrease in membrane fluidity and an increase in cytosolic Ca2+ concentration. These data suggest that in DVT there is a systemic granulocyte dysfunction, revealed especially after in vitro activation. This event might depend on the reactivity of the granulocyte to the chemotactic activation or to a granulocyte metabolic alteration. These granulocyte alterations after in vitro activation confirm other data (8, 9) that demonstrated, in subjects with venous disease, an increased systemic leukocyte susceptibility to activation and trapping.
